Purpose: Emerging studies have suggested that tumor necrosis factor-alpha (TNF-α) is implicated in the pathogenesis of Alzheimer’s disease (AD), and that cerebral glucose hypometabolism is a key feature of AD. However, the association of CSF TNF-α levels with changes in cerebral glucose metabolism has not been studied among non-demented older people. Patients and Methods: At baseline, there were a total of 214 non-demented older people from Alzheimer’s Disease Neuroimaging Initiative (ADNI) study. We examined the cross-sectional and longitudinal associations of CSF TNF-α with global cognition (as assessed by mini-mental state examination), verbal memory (as assessed by Rey Auditory Verbal Learning Test-total learning score), and cerebral glucose metabolism (as measured by FDF-PET). Linear mixed-effects models were used to examine the longitudinal association of CSF TNF-α with change in each outcome over time with adjustment of age, educational level, gender, and APOE4 status. Results: In the cross-sectional study, CSF TNF-α was negatively associated with MMSE scores, but not verbal memory or FDG-PET. In the longitudinal study, higher CSF TNF-α at baseline was associated with a faster decline in cerebral glucose metabolism, but not MMSE scores or RAVLT total learning scores. Conclusion: Higher CSF TNF-α levels were associated with a steeper decline in cerebral glucose metabolism among non-demented older people.
CITATION STYLE
Fu, P., Zhu, B., & Huang, Y. (2021). Csf tnf-α levels were associated with longitudinal change in brain glucose metabolism among non-demented older people. Neuropsychiatric Disease and Treatment, 17, 1659–1666. https://doi.org/10.2147/NDT.S291020
Mendeley helps you to discover research relevant for your work.